ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 46 filers reported holding ENOCHIAN BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $283,340 | +860.1% | 63,387 | +21.7% | 0.00% | – |
Q2 2023 | $29,512 | -89.5% | 52,087 | -83.1% | 0.00% | – |
Q1 2023 | $281,309 | -55.3% | 307,408 | -49.7% | 0.00% | – |
Q4 2022 | $629,552 | +9.9% | 611,216 | +93.2% | 0.00% | – |
Q3 2022 | $573,000 | -6.2% | 316,324 | -0.0% | 0.00% | – |
Q2 2022 | $611,000 | +42.1% | 316,469 | +507.6% | 0.00% | – |
Q1 2022 | $430,000 | +22.2% | 52,087 | +7.9% | 0.00% | – |
Q4 2021 | $352,000 | +8.3% | 48,291 | 0.0% | 0.00% | – |
Q3 2021 | $325,000 | +99.4% | 48,291 | +47.3% | 0.00% | – |
Q2 2021 | $163,000 | -75.5% | 32,791 | -82.6% | 0.00% | – |
Q1 2021 | $666,000 | +20.2% | 188,172 | +0.2% | 0.00% | – |
Q4 2020 | $554,000 | -19.6% | 187,872 | -2.4% | 0.00% | – |
Q3 2020 | $689,000 | +5.8% | 192,572 | +24.6% | 0.00% | – |
Q2 2020 | $651,000 | +76.9% | 154,517 | +25.9% | 0.00% | – |
Q1 2020 | $368,000 | +19.5% | 122,767 | +99.8% | 0.00% | – |
Q4 2019 | $308,000 | +76.0% | 61,441 | +93.2% | 0.00% | – |
Q3 2019 | $175,000 | +65.1% | 31,805 | -2.0% | 0.00% | – |
Q2 2019 | $106,000 | – | 32,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
Ergoteles LLC | 47,984 | $238,000 | 0.01% |
Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
UBS Group AG | 260 | $1,000 | 0.00% |